Delaney David 4
4 · Pasithea Therapeutics Corp. · Filed Oct 19, 2022
Insider Transaction Report
Form 4
Delaney David
Other
Transactions
- Purchase
Common Stock
2022-10-17$1.11/sh+1,000$1,110→ 227,521 total(indirect: See footnote)
Footnotes (2)
- [F1]The shares were purchased by Elderhill Corporation, of which David Delaney serves as sole director and President.
- [F2]191,321 shares are held by Concord IP2, Ltd., of which David Delaney serves as sole director and President, and 36,200 shares are held by Elderhill Corporation.